🧠Disrupting the medical pipeline for a healthier future in cancer patients. RENACER brings together a consortium of 15 national reference hospitals to challenge Brain Metastasis prevention and prognosis with a unique work strategy.
Discover RENACER 👉 https://t.co/eKtvB1gS5x
@CNIOStopCancer 🎤 "Building an Interoperable Brain Metastasis Data Infrastructure: The RENACER Network Experience" Advancing data quality, interoperability, and collaborative research in biobanking and brain metastasis research.
#Biobanking#DataQuality#BrainMetastasis#HealthData
📢 Proud to have Carmen Ortega-Sabater, Data Manager at the @CNIOStopCancer Biobank and member of the #RENACER Network, featured as a Highlight Speaker at #EBW26.
Tomorrow, June 2 🕤 9:30–14:35, the first edition of #BrainBreakingBad will take place at IIBM (CSIC-UAM).
👉 Program: https://t.co/4uE8W0q9on
👉 Registration: https://t.co/SX1Esn0ZdE
Free registration until full capacity.
#RENACER#BrainMetastasis#NeuroOncology
Stronger collaboration between patients, researchers and healthcare professionals could be key to making further progress in cancer research. Explore this central topic with experts in the sector in this episode of The Cancer Researcher Podcast 👉🔗https://t.co/1M6NRWqKOD
In this #EuropeanWeekAgainstCancer, Manuel Valiente, coordinator of #RENACER, reminds us that:
🤝fighting cancer is a collective effort
🎯it's still marked by major challenges such as prevention and metastasis
🧍♂️it's guided by the need to improve patients’ quality of life.
New step in brain cancer research 👉@H12Octubre, member of the #RENACER network, has enrolled the first patient in Spain in an international clinical trial of a new oral treatment for a type of brain tumour. Read the full news👉 https://t.co/C3UQ81TwaS
💡An example of the excellence behind #RENACER is Dr. Mariam Jamal-Hanjani, member of our Scientific Advisory Board,who received an ERC Synergy Grant 2025 for LUMES (LUng cancer Metastasis Evolutionary Studies). Congratulations! More about her career👉 https://t.co/TWcBssqXSg
📅Today, in #WorldHealthDay, we recognise all the actions that protect this fundamental right. At #RENACER, we contribute through research on brain metastases, helping build the knowledge that can ultimately be transformed into better #health.
#CancerResearch#Oncology
📢New insight into brain metastasis research! The brain metastasis group of the @CNIOStopCancer, led by @valientelab, published in Cancer Research, how tumour cells may redirect brain immune cells to support cancer progression. Read the full article: https://t.co/pKGyg8Ov6Y
📢The RENACER Newsletter is cooking...!
These past few months have been marked by major milestones, recognitions, and key events in advancing our mission to combat brain metastases. We tell you all about it in the new edition! Subscribe to discover it: https://t.co/4OOBLBS7Ml
💡At RENACER we are working to personalize the treatment of brain metastases, independent of the primary tumor. Our 3-years-long project called PerMEDperBRAIN was designed to this purpose. Discover our ongoing projects:https://t.co/agQKBdG9QJ
🔬 Only through research we can answer these questions, opening the door to better diagnoses, therapies and prevention. At RENACER, we have more than 20 centres where we conduct research to answer these types of questions and improve the lives of patients with brain metastases.
How signals between brain cells are integrated in disease development❓
Why only some cancer cells colonise the brain and others do not ❓
How do genetic alterations affect tumour development❓
📢The Volume II of “The Evolving Landscape of Brain Metastasis” in Trends in Cancer brings you insights on brain metastasis shaping research and treatment like these 👇
✏️ Brain metastasis has unique mechanisms that allow cancer cells to travel to the brain and survive there.
✏️ The disease remains a major challenge, affecting up to 30% of adult cancer patients.
✏️ Recent advances are offering new, more precise and integrated treatments.
📅 This week, RENACER joined @GEPAC_ at the VIII Spanish Cancer Summit, recognizing the vital role of the cancer advocacy movement. 💟Thank you for your essential work in supporting patients, advancing research, and strengthening collaboration in the fight against cancer.
📢 We want to thank @heraldoes, @elperiodico, @ConSalud_es, @infobae, and other media that have highlighted Volume II of Trends in Cancer, ‘The Evolving Landscape of Brain Metastasis’, published by Manuel Valiente's group. Thank you for helping science reach beyond the lab!